Indolo[2,3-a]quinolizidines and derivatives: Bioactivity and asymmetric Synthesis

Fecha de publicación

2016-06-13T15:27:47Z

2016-07-25T22:01:21Z

2015-07-25

2016-06-13T15:27:52Z

Resumen

Corynantheine alkaloids with a tetracyclic indole[2,3-a]-quinolizidine motif are an important issue in academia and in the life science industries due to their broad bioactivity profile. In particular, the main biological effects described for indoloquinolizidines include analgesic, anti-inflammatory, antihypertensive, and antiarrhythmic activities, as well as inhibition of multiple ion channels, affinity for opioid receptors, and activity against Leishmania. For that reason, in the last decades, numerous efforts have been invested in the development of novel synthetic strategies to obtain the indole[2,3-a]-quinolizidine system. This review focuses on the synthetic methodologies developed to target the most important alkaloids of this family, and highlights the potential use of these alkaloids or analogs to treat several diseases, ranging from cancer to neurodegenerative disorders.

Tipo de documento

Artículo


Versión aceptada

Lengua

Inglés

Publicado por

Bentham Science Publishers

Documentos relacionados

Versió postprint del document publicat a: http://dx.doi.org/10.2174/1381612821666151002112934

Current Pharmaceutical Design, 2015, vol. 21, num. 38, p. 5518-5546

http://dx.doi.org/10.2174/1381612821666151002112934

Citación recomendada

Esta citación se ha generado automáticamente.

Derechos

(c) Bentham Science Publishers, 2015